DNA damaging drugs-induced down-regulation of Bcl-2 is essential for induction of apoptosis in high-risk HPV-positive HEp-2 and KB cells

被引:16
作者
Singh, Sandeep [1 ]
Chhipa, Rishi Raj [1 ]
Vijayakumar, Maleppillil Vavachan [1 ]
Bhat, Manoj Kumar [1 ]
机构
[1] Natl Ctr Cell Sci, Pune 411007, Maharashtra, India
关键词
HPV-positive carcinoma; DNA damage; Bcl-2; promoter; apoptosis;
D O I
10.1016/j.canlet.2005.05.024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
DNA damaging chemotherapeutic agents like carboplatin (Carb) and 5-fluorouracil (5-FU), whose effects are mediated through diverse intracellular targets, induce apoptosis in various cancer cells including human papillomavirus (HPV) positive HEp-2 and KB cells. The present work reports the involvement of Bcl-2 in response to the exposure of HEp-2 and KB cells to Carb or 5-FU. We demonstrate that both these drugs are potent inducers of apoptosis. Apoptosis was preceded by decrease in Bcl-2 protein level accompanied by caspase-9 activation and poly(ADP-ribose) polymerase (PARP) cleavage without altering Bax expression. Further analysis revealed down-regulation of Bcl-2 mRNA as well as protein in drugs treated cells. Ectopic expression of Bcl-2 protected cells against drugs mediated DNA damage-induced apoptosis. Overall, data indicates that genotoxic stress leads to down-regulation of Bcl-2 in HEp-2 and KB cells, which plays a decisive role in the outcome of stress in these cells. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:213 / 221
页数:9
相关论文
共 28 条
  • [1] The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions
    Borner, C
    [J]. MOLECULAR IMMUNOLOGY, 2003, 39 (11) : 615 - 647
  • [2] CHEN M, 1995, CANCER RES, V55, P991
  • [3] Doxycycline potentiates antitumor effect of cyclophosphamide in mice
    Chhipa, RR
    Singh, S
    Surve, SV
    Vijayakumar, MV
    Bhat, MK
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2005, 202 (03) : 268 - 277
  • [4] Didelot C, 2003, INT J ONCOL, V23, P81
  • [5] Resistance to apoptosis of HPV 16-infected laryngeal cancer cells is associated with decreased Bak and increased Bcl-2 expression
    Du, J
    Chen, GG
    Vlantis, AC
    Chan, PKS
    Tsang, RKY
    van Hasselt, CA
    [J]. CANCER LETTERS, 2004, 205 (01) : 81 - 88
  • [6] Inducible loss of NF-κB activity is associated with apoptosis and Bcl-2 down-regulation in Epstein-Barr virus-transformed B lymphocytes
    Feuillard, J
    Schuhmacher, M
    Kohanna, S
    Asso-Bonnet, M
    Ledeur, F
    Joubert-Caron, R
    Bissières, P
    Polack, A
    Bornkamm, GW
    Raphaël, M
    [J]. BLOOD, 2000, 95 (06) : 2068 - 2075
  • [7] NF-κB activates Bcl-2 expression in t(14;18) lymphoma cells
    Heckman, CA
    Mehew, JW
    Boxer, LM
    [J]. ONCOGENE, 2002, 21 (24) : 3898 - 3908
  • [8] Kawakami K, 1999, ANTICANCER RES, V19, P3927
  • [9] Expression of human papillomavirus E7 mRNA in human oral and cervical neoplasia and cell lines
    Ke, LD
    Adler-Storthz, K
    Mitchell, MF
    Clayman, GL
    Chen, Z
    [J]. ORAL ONCOLOGY, 1999, 35 (04): : 415 - 420
  • [10] Therapeutic potential of antisense Bcl-2 as a chemosensitizer for cancer therapy
    Kim, R
    Emi, M
    Tanabe, K
    Toge, T
    [J]. CANCER, 2004, 101 (11) : 2491 - 2502